Goldman Sachs Maintains Sell on Clorox, Raises Price Target to $159
Goldman Sachs maintains Clorox (NYSE:CLX) with a Sell and raises the price target from $141 to $159.
Watching Clorox; Jim Cramer Tweets ‘they are buying Clorox again. That could ramble to $180 pretty easily’
https://twitter.com/jimcramer/status/1471135160208867332
Expert Ratings For Clorox
Clorox (NYSE:CLX) has observed the following analyst ratings within the last quarter:
Expert Ratings For Clorox
Analysts have provided the following ratings for Clorox (NYSE:CLX) within the last quarter:
DA Davidson Maintains Neutral on Clorox, Raises Price Target to $162
DA Davidson analyst Linda Bolton Weiser maintains Clorox (NYSE:CLX) with a Neutral and raises the price target from $145 to $162.
Clorox Q1 Earnings Beat Estimates, Notes Margin Pressure, Reaffirms FY22 Guidance
Clorox Co (NYSE:CLX) reported a first-quarter FY22 sales decline of 6% year-on-year, to $1.81 billion, beating the analyst consensus of $1.70…
JP Morgan Downgrades Clorox to Underweight, Lowers Price Target to $147
JP Morgan analyst Andrea Teixeira downgrades Clorox (NYSE:CLX) from Neutral to Underweight and lowers the price target from $171 to $147.
Recap: Clorox Q1 Earnings
Clorox (NYSE:CLX) reported its Q1 earnings results on Monday, November 1, 2021 at 04:15 PM.
Here's what investors need to know about the announcement.
Earnings
Clorox reported in-line EPS of $1.21 versus an estimate of $1.03, which surprised analysts.
Clorox Q1 EPS $1.21 Beats $1.03 Estimate, Sales $1.81B Beat $1.70B Estimate; Reaffirms Guidance
Clorox (NYSE:CLX) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.03 by 17.48 percent. This is a 62.42 percent decrease over earnings of $3.22 per share from the same period